A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease
Clinical trial NCT03819153 · COMPLETED
Trial details
- NCT number
- NCT03819153
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-17
- Primary completion
- 2024-01-09
- Enrollment
- 3533
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.